Results 41 to 50 of about 16,231 (238)

Assessment of the face validity, feasibility and utility of a patient-completed questionnaire for polymyalgia rheumatica: a postal survey using the QQ-10 questionnaire. [PDF]

open access: yes, 2017
BACKGROUND: The development of a patient-reported outcome measure (PROM) for polymyalgia rheumatica (PMR), a condition that causes pain, stiffness and disability, is necessary as there is no current validated disease-specific measure.
B Dasgupta   +14 more
core   +4 more sources

POLYMYALGIA RHEUMATICA [PDF]

open access: yesThe Journal of Bone and Joint Surgery. British volume, 1971
1. Polymyalgia rheumatica is a disease of unknown cause, manifested by severe pain and stiffness of the muscles of the shoulder and pelvic girdles, which may be accompanied by a variety of other systemic symptoms. 2. Twenty-three patients with this condition are reviewed. 3. The difficulties of diagnosis, especially when presenting as an orthopaedic
A G, Mowat, A V, Camp
openaire   +2 more sources

What is the absolute risk of developing diabetes mellitus in patients with glucocorticoid-treated polymyalgia rheumatica and giant cell arteritis? a systematic review and meta-analysis [PDF]

open access: yes, 2017
Background: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are treated with glucocorticoids (GCs) but long-term GC use is associated with diabetes mellitus (DM).
Harris, Emma   +3 more
core   +1 more source

Severe cholestatic hepatitis due to large vessel vasculitis: report of two cases [PDF]

open access: yes, 2018
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesGiant cell arteritis (GCA) is a vasculitis of medium and large sized vessels ...
Björnsson, Einar S.   +2 more
core   +1 more source

Development and evaluation of disease-specific patient-reported outcome measures questionnaire for polymyalgia rheumatica: validity, reliability, and responsiveness

open access: yesEgyptian Rheumatology and Rehabilitation
Background Polymyalgia rheumatica is an inflammatory disease characterized by stiffness and pain around the proximal muscles of both arms and hips and a peak incidence in adults over 50 years of age.
Yasser El Miedany   +6 more
doaj   +1 more source

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial

open access: yesArthritis &Rheumatology, Volume 77, Issue 8, Page 1041-1051, August 2025.
Objective An unmet need exists for glucocorticoid‐sparing treatments for patients with polymyalgia rheumatica (PMR). The antibody‐drug conjugate ABBV‐154 comprises adalimumab conjugated to a glucocorticoid receptor modulator. We evaluated ABBV‐154 versus placebo in patients with glucocorticoid‐dependent PMR.
Robert F. Spiera   +14 more
wiley   +1 more source

New insights into the pathogenesis of giant cell arteritis [PDF]

open access: yes, 2016
Giant cell arteritis (GCA) is an inflammatory chronic disease occurring exclusively in elderly individuals. Until recently, the disease has been considered a unique disease resulting from the interaction in the walls of susceptible arteries, between an ...
Francesco Ciccia   +110 more
core   +3 more sources

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

open access: yesArthritis &Rheumatology, EarlyView.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim   +5 more
wiley   +1 more source

If something looks like an apple, is it necessarily an apple? Some considerations about so-called “statin-induced polymyalgia rheumatica”

open access: yesRheumatology, 2019
The existence of polymyalgia rheumatica (PMR) induced by statins has been hypothesised by some investigators. This review article highlights the fact that there is no evidence it is real.
Ciro Manzo
doaj   +1 more source

Enlarging Liver Mass: Inflammatory Pseudotumor in a Patient With Polymyalgia Rheumatica

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Inflammatory pseudotumors of the liver are rare, non-neoplastic liver tumors. Due to the nonspecific clinical presentation, imaging features, and histopathological findings, they can mimic malignant tumors requiring invasive diagnostics.
Gowthami Kanagalingam MD   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy